BIO-key International Inc. (NASDAQ:BKYI) Stock Short Interest Falls 61.2%

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 386,470 shares, a decrease of 61.2% from the September 30th total of 995,329 shares. Approximately 19.8% of the shares of the company are sold short. Based on an average daily trading volume, of 7,692,228 shares, the days-to-cover ratio is currently 0.1 days.

BIO-key International Stock Performance

Shares of BIO-key International stock traded down $0.23 during trading hours on Friday, hitting $2.70. The company’s stock had a trading volume of 293,196 shares, compared to its average volume of 8,609,318. The business has a 50 day moving average price of $2.58 and a two-hundred day moving average price of $4.57. BIO-key International has a 12-month low of $1.55 and a 12-month high of $13.80. The company has a market cap of $5.51 million, a PE ratio of -0.66 and a beta of 0.50.

BIO-key International (NASDAQ:BKYI) last released its earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. The firm had revenue of $1.92 million during the quarter, compared to analysts’ expectations of $1.80 million. As a group, research analysts anticipate that BIO-key International will post -1.62 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on BKYI shares. Zacks Research raised BIO-key International to a “hold” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. Finally, Wall Street Zen raised shares of BIO-key International to a “hold” rating in a report on Saturday, October 24th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.

About BIO-key International

BIO-key International, Inc (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords.

Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.